Insiders / Haas Jason
Haas Jason
CIK 1883821personinsider
Companies
3
First seen
Oct 13, 2021
Last activity
Aug 14, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Odyssey Therapeutics, Inc. · ODTX | 62,908 | — |
| Ligand Pharmaceuticals Inc · LGND | 3,981 | — |
| Syros Pharmaceuticals, Inc. · SYRS | 0 | — |
All securities held
3 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Ligand Pharmaceuticals Inc | Common stock | 3,981 |
| Odyssey Therapeutics, Inc. | Common stock | 62,908 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Syros Pharmaceuticals, Inc. | Options | 49,750 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Sell Open-market sale | LGND Ligand Pharmaceuticals Inc Common Stock | $2.09M | -7K -64.20% | 3,981 0.02% of shares | medium |
| Jun 12, 2026 | Sell Open-market sale | LGND Ligand Pharmaceuticals Inc Common Stock | $886.3K | -3K -41.00% | 4,981 0.02% of shares | medium |
| Jun 12, 2026 | Sell Open-market sale | LGND Ligand Pharmaceuticals Inc |